全部 标题 作者 关键词 摘要
Full-Text Cite this paper Add to My Lib
A patient-centred paradigm for the biosimilars marketSouth Korean guidelines for biosimilarsIndian Government issues first compulsory licence
Full-Text
Contact Us
service@oalib.com
QQ:3279437679
WhatsApp +8615387084133